Herpes Simplex Virus Type 1 Infection of Isogenic Epstein-Barr Virus Genome-Negative and -Positive Burkitt's Lymphoma-Derived Cell Lines
- 1 April 1979
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 30 (1) , 248-254
- https://doi.org/10.1128/jvi.30.1.248-254.1979
Abstract
The Epstein-Barr virus (EBV) genome-negative Burkitt's lymphoma-derived cell lines BJAB and Ramos and their in vitro EBV-converted sublines BJAB-B1, BJAB-A5, BJAB-B95-8, and AW-Ramos were infected with high multiplicities of herpes simplex virus type 1 (HSV-1; 10 to 70 PFU/cell). Cultures were monitored for cell growth and HSV-1 DNA synthesis. EBV-converted BJAB cultures were more permissive for HSV-1 infection than BJAB cultures. Significant cell killing and HSV-1 DNA synthesis were observed during the first 48 h of infection in the EBV-converted BJAB cultures but not in the BJAB cultures. The EBV-converted BJAB-B1 cell line contains an appreciable fraction of EBV-negative cells. Therefore, it was cloned. EBV-positive and -negative cells were identified by using EBV-determined nuclear antigen anti-complement immunofluorescence. Two types of subclones were identified: (i) those which contained both EBV-determined nuclear antigen-positive and -negative cells and (ii) those which contained only EBV-determined nuclear antigen-negative cells. When levels of HSV-1 DNA synthesis were measured in these subclones, it was found that the former were more permissive for HSV-1 infection than the latter. Thus, the presence of the EBV genome in BJAB cells correlates with increased permissiveness of these cells for HSV-1 during the first 48 h of infection. Nonetheless, persistent HSV-1 infections were established in both BJAB and EBV-converted BJAB-B1 cultures. No differences in extent of permissiveness for HSV-1 infection were found for Ramos and EBV-converted AW-Ramos cells.This publication has 19 references indexed in Scilit:
- Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and epstein‐barr virus (EBV)‐positive and ‐negative B lymphoid cell linesInternational Journal of Cancer, 1977
- Heterogeneity of epstein‐barr virus originating from P3HR‐1 cells. I. Studies on ebna inductionInternational Journal of Cancer, 1977
- Inducibility of the Epstein‐Barr virus (EBV) cycle and surface marker properties of ebv‐negative lymphoma lines and their in vitro EBV‐converted sublinesInternational Journal of Cancer, 1976
- Persistent Herpes Simplex Virus Infections Established in Two Burkitt Lymphoma Derived Cell LinesJournal of General Virology, 1976
- Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitroVirology, 1976
- Difference in antibody induced redistribution of membrane IgM in EBV-genome free and EBV positive human lymphoid cellsExperimental Cell Research, 1976
- Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strainsInternational Journal of Cancer, 1976
- Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.Proceedings of the National Academy of Sciences, 1975
- Production by EBV infection of an EBNA‐positive subline from an EBNA‐negative human lymphoma cell line without detectable EBV DNAInternational Journal of Cancer, 1975
- An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by in vitro InfectionIntervirology, 1975